Loomis, Sayles & Company
NTUS

Loomis, Sayles & Company’s Natus Medical Inc NTUS Stock Holding History

Loomis, Sayles & Company’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-190
Closed -$7K – 972
2017
Q3 		$7K Hold
190
– – ﹤0.01% 827
2017
Q2 		$7K Hold
190
– – ﹤0.01% 846
2017
Q1 		$7K Buy
+190
New +$7.13K ﹤0.01% 847
2016
Q2 		– Sell
-573,333
Closed -$22M – 1151
2016
Q1 		$22M Sell
573,333
-3,040
-0.5% -$113K 0.06% 229
2015
Q4 		$27.7M Buy
576,373
+61,140
+12% +$2.83M 0.08% 191
2015
Q3 		$20.3M Buy
+515,233
New +$21.9M 0.06% 278
2015
Q1 		– Sell
-5,967
Closed -$215K – 780
2014
Q4 		$215K Sell
5,967
-5,779
-49% -$194K ﹤0.01% 633
2014
Q3 		$347K Buy
11,746
+2,576
+28% +$71.1K ﹤0.01% 607
2014
Q2 		$231K Hold
9,170
– – ﹤0.01% 649
2014
Q1 		$237K Hold
9,170
– – ﹤0.01% 630
2013
Q4 		$206K Buy
+9,170
New +$177K ﹤0.01% 682

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company's NTUS Position: Q4 2017 in Review

Loomis, Sayles & Company sold out of Natus Medical Inc (NTUS) in Q4 2017, closing a stake of 190 shares — an estimated $7K sold.

Loomis, Sayles & Company first reported a position in NTUS in Q4 2013 and held it in 11 quarters. The position peaked at $27.7M in Q4 2015. 214 funds tracked by Wall St. Rank hold NTUS as of Q4 2017.

  • Loomis, Sayles & Company reported no remaining Natus Medical Inc position as of Q4 2017 after selling out during the quarter.
  • Loomis, Sayles & Company sold 190 Natus Medical Inc shares in Q4 2017, an estimated $7K.
  • Loomis, Sayles & Company first reported a position in Natus Medical Inc in Q4 2013 and held it in 11 quarters.
  • Loomis, Sayles & Company's Natus Medical Inc position peaked at $27.7M in Q4 2015.
  • 214 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2017.

Based on Loomis, Sayles & Company's 13F filing for Q4 2017, filed 14 Feb 2018.